| Bioactivity | ELOVL1-IN-3 (Compound 22) is a potent and orally active inhibitor of elongation of very long chain fatty acid 1 (ELOVL1) enzyme. ELOVL1-IN-3 serves as a useful tool for researching adrenoleukodystrophy (ALD)[1]. | |||||||||
| Target | ELOVL1 | |||||||||
| Name | ELOVL1-IN-3 | |||||||||
| CAS | 2761063-99-2 | |||||||||
| Formula | C21H23N5O2 | |||||||||
| Molar Mass | 377.44 | |||||||||
| Appearance | Oil | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Boyd MJ, et al. Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1. J Med Chem. 2021;64(24):17777-17794. |
ELOVL1-IN-3
CAS: 2761063-99-2 F: C21H23N5O2 W: 377.44
ELOVL1-IN-3 (Compound 22) is a potent and orally active inhibitor of elongation of verylong chain fatty acid 1 (ELOVL1)
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.